StockData
Altimmune, Inc. logo

Altimmune, Inc. (ALT) bonds

ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.56−0.08 (-5.17%)

Close on Nov 16, 2026Market cap $303.45MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$34.74M
Long-term debt
Net debt
-$28.27M
After $63.01M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
-57.8×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in Altimmune's 10-Q for the period ended Nov 5, 2025

IssueCouponAmount issued
First term loan tranche–$15.00M
Fourth term loan tranche–$80.00M
Second term loan tranche–$20.00M
Term loan9.70%$125.00M
Third term loan tranche–$10.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?